skip to primary navigationskip to content
 

ERC grant for David Fairen-Jimenez

last modified Nov 21, 2016 02:57 PM
A new generation of nanocapsules for drug delivery and bioimaging in cancer diagnosis and therapy

Dr David Fairen-Jimenez has been awarded a European Research Council (ERC) Consolidator Grant of €1.9 million. Set  up  in  2007  by  the  European  Commission,  the  ERC  is  the  first European funding organisation to pursue the most promising avenues at the frontier of science. ERC Consolidator Grants are to strengthen researchers' independence and help them establish themselves as leaders in their scientific fields. In particular, David’s proposal focuses on the design and development of a new generation of nanocapsules for drug delivery and bioimaging in cancer diagnosis and therapy. These nanocapsules consist on enhanced metal-organic frameworks (MOFs), one of the most exciting developments in recent porous materials science as a way to protect and deliver therapeutic agents including macromolecules such as small peptides and RNA.

David joined Cambridge in late 2012 as a Royal Society University Research Fellow, and leads the Adsorption & Advanced Materials Lab. His research interests are related to the evaluation of novel strategies in the design and development of advanced materials and supramolecular assemblies, as well as the creation of new experimental and computational methods for the prediction of their performance. In addition to drug delivery systems, David’s research is extended towards the development of functional materials for the necessary shift from today’s fossil-based energy economy to a more sustainable economy based on hydrogen, renewable energy and carbon capture to mitigate the effects of global warming. His work has been published in more than 55 high-impact journal publications (h-index: 23) including Angewandte Chem., JACS, Chem. Commun., etc.